Profile data is unavailable for this security.
About the company
Devonian Health Group Inc. is a Canada-based late-stage botanical pharmaceutical company. The Company is focused on developing prescription botanical drugs from plant materials and algae for the treatment of inflammatory autoimmune diseases, including but not limited to ulcerative colitis and atopic dermatitis. It is also involved in the development of high-value cosmeceutical products leveraging the same proprietary approach employed with their pharmaceutical offerings. Its flagship product, Thykamine, is a pharmaceutical product issued from its SUPREX platform, for the prevention and treatment of health conditions related to inflammation and oxidative stress, including ulcerative colitis, atopic dermatitis, psoriasis, and other autoimmune diseases. Its cosmeceutical products include R-Spinasome and Purgenesis. Its subsidiary, Altius Healthcare Inc., is focused on selling prescription pharmaceutical products in Canada, under license from brand name pharmaceutical companies.
- Revenue in CAD (TTM)9.75m
- Net income in CAD-3.17m
- Incorporated2017
- Employees6.00
- LocationDevonian Health Group Inc360 rue des EntrepreneursMONTMAGNY G5V 4T1CanadaCAN
- Phone+1 (514) 248-7509
- Fax+1 (450) 937-6696
- Websitehttps://groupedevonian.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Willow Biosciences Inc | 1.84m | -8.70m | 12.98m | 19.00 | -- | -- | -- | 7.05 | -0.0695 | -0.0695 | 0.0147 | -0.0004 | 0.249 | -- | 111.52 | 96,842.10 | -117.73 | -- | -164.04 | -- | -- | -- | -472.83 | -- | 0.6479 | -- | 1.03 | -- | 42.75 | -- | 12.05 | -- | -- | -- |
| Kane Biotech Inc | 757.12k | -5.48m | 13.18m | -- | -- | -- | -- | 17.41 | -0.042 | 0.0374 | 0.0059 | -0.0055 | 0.1568 | 0.3751 | 3.23 | -- | -113.43 | -77.89 | -- | -- | 60.54 | 43.27 | -723.31 | -241.85 | 0.5679 | -4.73 | 1.43 | -- | -94.42 | -20.26 | -17.29 | -- | -19.41 | -- |
| Cytophage Technologies Ltd | 0.00 | -7.80m | 13.48m | -- | -- | 2.56 | -- | -- | -0.3779 | -0.3779 | 0.00 | 0.0978 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.2374 | -- | -- | -- | -25.88 | -- | -- | -- |
| Pharmacielo Ltd | 1.62m | -14.15m | 15.82m | 268.00 | -- | -- | -- | 9.76 | -0.0849 | -0.0849 | 0.0097 | -0.032 | 0.0699 | 1.38 | 24.15 | -- | -61.03 | -- | -165.82 | -- | -86.39 | -- | -873.57 | -- | 0.039 | -2.48 | 1.37 | -- | -70.96 | -- | -12.27 | -- | -- | -- |
| Devonian Health Group Inc | 9.75m | -3.17m | 22.97m | 6.00 | -- | 1.72 | -- | 2.36 | -0.0216 | -0.0216 | 0.0665 | 0.09 | 0.4423 | 33.07 | 2.32 | 1,625,238.00 | -14.37 | -21.02 | -23.15 | -23.96 | 30.95 | 29.96 | -32.50 | -131.97 | 1.06 | -9.41 | 0.1406 | -- | 1.74 | -5.83 | -33.39 | -- | -- | -- |
| Charlotte's Web Holdings Inc | 75.87m | -61.78m | 28.35m | 164.00 | -- | 0.5689 | -- | 0.3737 | -0.4004 | -0.4004 | 0.4906 | 0.3164 | 0.3561 | 1.34 | 25.09 | 462,627.60 | -29.00 | -25.71 | -33.48 | -29.03 | 48.07 | 48.98 | -81.43 | -63.11 | 2.07 | -42.57 | 0.5481 | -- | -14.82 | -1.90 | 59.88 | -- | -7.88 | -- |
| Decibel Cannabis Company Inc | 101.04m | -563.00k | 28.63m | -- | -- | 0.6647 | 8.72 | 0.2834 | -0.0016 | -0.0096 | 0.2349 | 0.1053 | 0.7555 | 1.64 | 6.86 | -- | -0.421 | -3.55 | -0.6781 | -5.19 | 26.70 | 15.77 | -0.5572 | -7.13 | 0.3644 | -3.03 | 0.5178 | -- | 46.18 | -- | 60.33 | -- | -32.45 | -- |
| Medipharm Labs Corp | 37.76m | -13.49m | 28.77m | 166.00 | -- | 0.6043 | -- | 0.7621 | -0.0378 | -0.0378 | 0.1033 | 0.1158 | 0.5662 | 2.75 | 3.82 | 227,451.80 | -20.22 | -32.88 | -24.86 | -39.56 | 23.80 | -5.88 | -35.72 | -67.66 | 2.33 | -- | 0.0557 | -- | 49.49 | 26.52 | 56.37 | -- | -49.66 | -- |
